Method for preparing indole glycoside through biocatalytic conversion of tryptophan
By designing a co-culture system for glucosyltransferase mutation and double strains, combining NADPH regeneration system and UDP-glucose circulation system, the reaction conditions are optimized, and the problems of large energy consumption and complex composition during indole glycoside extraction are solved, and the problem of large energy consumption and complex composition is achieved. Efficient and low-cost biocatalytic preparation, with significantly improved yield and conversion rates.
Patent Information
- Application Number
- CN202411168378.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-19
AI Technical Summary
In the prior art, the extraction process of indole glycosides consumes a large energy, severe reagent contamination, complex extract composition, and the extraction rate is affected by seasons and leaf growth conditions, making it difficult to be suitable for large-scale preparation.
By performing site-directed mutation modification of glucosyltransferase, combined with the combination of tryptophan enzymes, flavin-dependent monooxygenase, glucose dehydrogenase and other enzymes, a double strain co-culture system was established, and the NADPH regeneration system and UDP- Glucose circulatory system optimizes reaction conditions to improve indole glycoside yield and conversion.
The high-efficiency and low-cost biocatalytic conversion of tryptophan to prepare indole glycoside was achieved, with the highest yield reaching 911.8 mg/L and the molar conversion rate was 42.1%, reducing the consumption of NADPH and the preparation cost.
Smart Images

Figure CN118979086A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioengineering, and in particular relates to a method for preparing indole glycosides by biocatalytic conversion of tryptophan. Background Art
[0002] Indole glycoside (Indican) is a glycoside alkaloid compound, which is a glycoside formed by the condensation of the indole hydroxyl group in its aglycone structure and the carbon atom at the end of the sugar. Indole glycosides are naturally present in a variety of indigo-producing plants, such as the stems and leaves of Indigo and Polygonum tinctorium, and are stable and easy to store. At present, indole glycosides are considered to be important raw materials for antibacterial, antiviral, and antitumor drugs, and are also precursors for the conversion and production of indigo and indirubin. Indigo, as an ancient dye, has a wide range of application value in the food, medicine, printing and dyeing, cosmetics and other industries, while indirubin is an indigo isomer, a class of bis-indole anti-tumor drugs with outstanding pharmacological effects. Clinically, it has been shown to have an inhibitory effect on a variety of transplanted animal tumors and has been used in the treatment of chronic myeloid leukemia. Therefore, indole glycosides are of great value in the development of drug intermediates or daily chemical raw materials.
[0003] At present, plant extraction is the main way to obtain indole glycosides, but the extraction process consumes a lot of energy, the reagents are seriously polluted, the extract composition is complex, and the extraction rate is greatly affected by the season and the growth of leaves. It is not suitable for large-scale preparation of indole glycosides. In recent years, metabolic engineering through the transformation of the metabolic system of cultured organisms has become an important means to synthesize secondary metabolites with biological activity, which provides a new idea for the heterologous biosynthesis of indole glycosides, but there are still problems such as low conversion rate and high preparation cost. Summary of the invention
[0004] The purpose of this section is to summarize some aspects of embodiments of the present invention and briefly introduce some preferred embodiments. Some simplifications or omissions may be made in this section and the specification abstract and the invention title of this application to avoid blurring the purpose of this section, the specification abstract and the invention title, and such simplifications or omissions cannot be used to limit the scope of the present invention.
[0005] In view of the above problems and / or the problems existing in the prior art, the present invention is proposed.
[0006] One of the purposes of the present invention is to provide a method for preparing indole glycosides by biocatalytic conversion of tryptophan, wherein the glycosylation efficiency of glucosyltransferase is improved by site-directed mutagenesis. The introduction of the cofactor NADPH regeneration system is conducive to reducing the preparation cost, and the dual-strain co-culture system can reduce the metabolic burden of heterologous synthesis, which is conducive to increasing the yield of indole glycosides.
[0007] In order to solve the above technical problems, the present invention provides the following technical solutions: a method for preparing indole glycosides by biocatalytic conversion of tryptophan, comprising: using tryptophanase, flavin-dependent monooxygenase, glucosyltransferase, glucose dehydrogenase in combination or using recombinant bacteria of the above enzymes in combination, using tryptophan as a substrate to biocatalytically prepare indole glycosides;
[0008] Wherein, the tryptophanase comprises one of TnaA from Haliscomenobacter hydrossis DSM 1100, Sediminispirochaetasmaragdinae DSM 11293, and Escherichia coli B21 (DE3);
[0009] The flavin-dependent monooxygenase includes one of the FMOs derived from Hydrogenovibrio sp. JE_KL2, Pseudomonadotabacterium, and Methylophaga sp. strain SK1;
[0010] The glucosyltransferase is a mutant of the glucosyltransferase PtUGT2 derived from Polygala tenuifolia, and the mutant is obtained by replacing the methionine at position 91 with alanine and the serine at position 145 with alanine in the amino acid sequence of the glucosyltransferase PtUGT2;
[0011] The glucose dehydrogenase includes GDH derived from Bacilus subtilis.
[0012] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, the tryptophanase is selected from TnaA from Escherichia coli B21 (DE3), and the nucleotide sequence encoding the TnaA is shown in SEQ ID NO.1;
[0013] The flavin-dependent monooxygenase is selected from FMO derived from Methylophaga sp. strain SK1, and the nucleotide sequence encoding the FMO is shown in SEQ ID NO.3;
[0014] The nucleotide sequence encoding the glucosyltransferase PtUGT2 mutant is shown in SEQ ID NO.7;
[0015] The amino acid sequence of the GDH is shown in SEQ ID NO.9.
[0016] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, wherein: the biocatalytic reaction uses tryptophan as a substrate, the first recombinant bacteria and the second recombinant bacteria are co-inoculated, and the OD 600 is 0.6-2.2, the concentration of IPTG added is 0-0.9 mM, the induction temperature is 20-37°C, the fermentation temperature is 20-37°C, the cellobiose concentration is 0-20 g / L, and the NADP + The concentration is 0-1.5 mM, the glucose concentration is 0-100 mM, and the substrate tryptophan concentration is 1.5 g / L.
[0017] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, wherein: the biocatalytic reaction uses tryptophan as a substrate, the recombinant bacteria are inoculated, and cultured until the biomass OD 600 is 0.6-0.8, the concentration of IPTG added is 0.2mM, the induction temperature is 20℃, the fermentation temperature is 30℃, the cellobiose concentration is 10g / L, and the NADP + The concentration was 1 mM, the glucose concentration was 10 mM, and the substrate tryptophan concentration was 1.5 g / L.
[0018] Another object of the present invention is to provide a method for preparing indole glycosides by biocatalytic conversion of tryptophan, comprising:
[0019] The indole glycosides are prepared by biocatalysis using tryptophan as a substrate by combining tryptophanase, flavin-dependent monooxygenase, glucosyltransferase, glucose dehydrogenase, cellobiose phospholyase, glucose-1-phosphate uridyltransferase or combining recombinant bacteria of the above enzymes;
[0020] Wherein, the tryptophanase comprises one of TnaA from Haliscomenobacter hydrossis DSM 1100, Sediminispirochaetasmaragdinae DSM 11293, and Escherichia coli B21 (DE3);
[0021] The flavin-dependent monooxygenase includes one of the FMOs derived from Hydrogenovibrio sp. JE_KL2, Pseudomonadotabacterium, and Methylophaga sp. strain SK1;
[0022] The glucosyltransferase is a mutant of the glucosyltransferase PtUGT2 derived from Polygala tenuifolia, and the mutant is obtained by replacing the methionine at position 91 with alanine and the serine at position 145 with alanine in the amino acid sequence of the glucosyltransferase PtUGT2;
[0023] The glucose dehydrogenase includes GDH derived from Bacilus subtilis;
[0024] The cellobiose phospholyase includes Cep derived from Saccharophagus degradans;
[0025] The glucose-1-phosphate uridyltransferase includes UgpA derived from Bifidobacterium bifidum.
[0026] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, the tryptophanase is selected from TnaA from Escherichia coli B21 (DE3), and the nucleotide sequence encoding the TnaA is shown in SEQ ID NO.1;
[0027] The flavin-dependent monooxygenase is selected from FMO derived from Methylophaga sp. strain SK1, and the nucleotide sequence encoding the FMO is shown in SEQ ID NO.3;
[0028] The nucleotide sequence encoding the glucosyltransferase PtUGT2 mutant is shown in SEQ ID NO.7;
[0029] The amino acid sequence of the GDH is shown in SEQ ID NO.9;
[0030] The amino acid sequence of Cep is shown in SEQ ID NO.10;
[0031] The amino acid sequence of UgpA is shown in SEQ ID NO.11.
[0032] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, the recombinant bacteria comprises a first recombinant bacteria and a second recombinant bacteria, the first recombinant bacteria contains a nucleotide sequence encoding tryptophanase TnaA and a nucleotide sequence encoding flavin-dependent monooxygenase FMO;
[0033] The second recombinant bacterium contains a nucleotide sequence encoding a mutant of a glucosyltransferase PtUGT2, a nucleotide sequence encoding a glucose dehydrogenase GDH, a nucleotide sequence encoding a cellobiose phospholyase Cep, and a nucleotide sequence encoding a glucose-1-phosphate uridyltransferase UgpA;
[0034] The first recombinant bacteria and the second recombinant bacteria are jointly used for biocatalytic reaction at a strain inoculation ratio of 1:9 to 9:1.
[0035] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, wherein: the biocatalytic reaction uses tryptophan as a substrate, the first recombinant bacteria and the second recombinant bacteria are co-inoculated, and the OD 600 is 0.6-2.2, the concentration of IPTG added is 0-0.9 mM, the induction temperature is 20-37°C, the fermentation temperature is 20-37°C, the cellobiose concentration is 0-20 g / L, and the NADP + The concentration is 0-1.5 mM, the glucose concentration is 0-100 mM, and the substrate tryptophan concentration is 1.5 g / L.
[0036] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, wherein: the biocatalytic reaction uses tryptophan as a substrate, the inoculation ratio of the first recombinant bacteria to the second recombinant bacteria is 1:1, and the OD 600 was 1.4, the IPTG concentration was 0.1 mM, the induction temperature was 20°C, the fermentation temperature was 30°C, the cellobiose concentration was 10 g / L, and the NADP + The concentration is 1 mM, the glucose concentration is 10 mM and the substrate tryptophan concentration is 1.5 g / L.
[0037] As a preferred embodiment of the method for preparing indole glycosides by biocatalytic conversion of tryptophan of the present invention, the reaction time is 48 hours and the in vivo conversion rate of indole glycosides is 42.05%.
[0038] Compared with the prior art, the present invention has the following beneficial effects:
[0039] The present invention provides a method for biosynthesizing indole glycosides by co-transformation of two strains, and creates a new approach and technology for preparing indole glycosides. The present invention utilizes tryptophanase TnaA, flavin-dependent monooxygenase FMO, glucosyltransferase PtUGT2 mutant, UDP-glucose circulation system and NADPH regeneration system to establish a process for biosynthesizing indole glycosides using tryptophan as a substrate, and rationally splits the metabolic pathways through a co-culture system, thereby creating a new method for biosynthesizing indole glycosides with high efficiency and low cost.
[0040] In the co-culture system established by the present invention, the metabolic pathway is split into the preparation of indole phenol and the transglycosylation, and the NADPH regeneration system and the UDP-glucose circulation system are introduced, which greatly reduces the consumption of NADPH and the preparation cost of indole glycosides. A process for preparing indole glycosides by co-culture biosynthesis with tryptophan as a substrate is established. By optimizing the reaction conditions of the co-culture system, the maximum yield of indole glycosides reaches 911.8 mg / L, and the molar conversion rate is 42.1%. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for describing the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative labor. Among them:
[0042] Figure 1 Schematic diagram of the bioconversion of tryptophan into indole glycosides by the co-culture system of the present invention;
[0043] Figure 2 The effect of overexpression of tnaA on the tryptophan catalysis ability of the strain in Example 1 of the present invention;
[0044] Figure 3 This is a comparison diagram of the enzyme activities of the recombinant enzyme and the mutant enzyme in Example 2 of the present invention;
[0045] Figure 4 The effect of NADPH and its regeneration system on the yield of indole glycosides in Example 3 of the present invention;
[0046] Figure 5 The reaction conditions of the NADPH regeneration system in Example 4 of the present invention are optimized; wherein a is the optimization of glucose concentration; b is NADP + Optimization of concentration;
[0047] Figure 6 The effect of co-culture and UDP-glucose circulation system on indole glycoside production in Example 5 of the present invention;
[0048] Figure 7 The fermentation medium and substrate addition conditions of the co-culture system in Example 6 of the present invention are optimized; wherein a is the optimization of the carbon source type; b is the optimization of the carbon source concentration; c is the optimization of the oxygen content; d is the optimization of the substrate addition amount; and e is the optimization of the timing of substrate addition.
[0049] Figure 8 The co-culture system culture and reaction conditions in Example 7 of the present invention are optimized; wherein, a is the optimization of the inoculation ratio; b is the optimization of the cellobiose concentration; c is the optimization of the IPTG concentration; d is the optimization of OD600; e is the optimization of the induction temperature; and f is the optimization of the reaction temperature. DETAILED DESCRIPTION
[0050] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are described in detail below in conjunction with the embodiments of the specification.
[0051] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention may also be implemented in other ways different from those described herein, and those skilled in the art may make similar generalizations without violating the connotation of the present invention. Therefore, the present invention is not limited to the specific embodiments disclosed below.
[0052] Secondly, the term "one embodiment" or "embodiment" as used herein refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the present invention. The term "in one embodiment" that appears in different places in this specification does not necessarily refer to the same embodiment, nor does it refer to a separate or selective embodiment that is mutually exclusive with other embodiments.
[0053] Unless otherwise specified, the raw materials used in the examples were purchased commercially.
[0054] In the embodiment, the culture medium used is:
[0055] (1) Luria-Bertani (LB) medium: Weigh 10 g Tryptone, 5 g Yeast extract, and 10 g NaCl, dissolve in distilled water and dilute to 1 L (adjust pH to 7.0-7.5 with NaOH), and sterilize at 121°C for 20 min. When preparing LB solid medium, add 20 g / L agar powder before high-pressure steam sterilization.
[0056] (2) Terrific Broth (TB) medium: Solution A: Weigh 12 g Tryptone and 24 g Yeast extract, add distilled water to dissolve and make up to 900 mL, sterilize at 121°C for 20 min. Solution B: Weigh 16.43 g K2HPO4 and 2.31 g KH2PO4, add water to make up to 100 mL, prepare before use, sterilize with a 0.22 μm membrane in a clean bench, and add to Solution A.
[0057] The DNA polymerase used in the examples ( FastPfu DNA Polymerase), pEASY-Basic Seamless Cloning and Assembly Kit, deoxyribonucleic acid (dNTP), ligase (T4 DNA ligase), phosphorylase (T4 Polynucleotide Kinase) and related buffers were purchased from Quanshijin (Beijing) Biotechnology Co., Ltd.
[0058] Tryptophan used in the examples was purchased from Shanghai Shenggong Biotechnology Co., Ltd., and indole glycoside was purchased from Nanjing Yuanzhi Biological Co., Ltd.
[0059] The test method used in the embodiment of the present invention is:
[0060] Remaining tryptophan = the remaining tryptophan content in the system / 7.34×100%;
[0061] Relative indole glycoside production = indole glycoside production obtained by the designed system / indole glycoside production of the control group × 100%;
[0062] Molar conversion rate = (indole glycoside yield / 295.29) / 7.34×100%.
[0063] Example 1 Cloning of tryptophanase TnaA and flavin-dependent monooxygenase FMO and construction of indoxyl production strain
[0064] (1) Cloning of tryptophanase TnaA
[0065] The genome of Escherichia coli B21(DE3) was used as a template, and two specific primers upstream and downstream of tryptophanase TnaA were designed according to the conserved sequence.
[0066] Upstream primer: CATGCCATGGAAAATTTTAAACATCTGC;
[0067] Downstream primer: CCGCTCGAGATTAACTTCTTTCAGTTT.
[0068] PCR amplification was performed with the synthesized primers under the following conditions: 98°C, 3 min; 35 cycles (98°C, 10 s; 53°C, 20 s; 72°C, 86 s); 72°C, 10 min; reaction was stopped and kept at 4°C. The PCR amplification product was purified using a gel recovery kit. The tryptophanase TnaA gene from E. coli B21 (DE3) was obtained, and its nucleotide sequence is shown in SEQ ID NO.1, and its amino acid sequence is shown in SEQ ID NO.2.
[0069] The obtained plasmid and pETDuet-1 were double-digested with Nco I and Xhol I, respectively, the recovered fragments were connected to the pETDuet-1 vector, and the products were transformed into Escherichia coli E. coli DH5α. The transformation products were spread on LB plates and cultured at 37°C overnight. A single colony was inoculated into LB liquid culture medium (added with 100 μg / mL ampicillin) and cultured for 8 to 10 hours. The bacteria were collected to extract the plasmid, and the empty plasmid was removed by enzyme digestion verification. The recombinant plasmid was subjected to nucleic acid sequence determination to obtain the correct recombinant expression vector pETDuet-1-TnaA.
[0070] (2) Cloning of the flavin-dependent monooxygenase gene FMO
[0071] Flavin-dependent monooxygenase FMO (GenBank accession No. AF494423.2) was synthesized in the vector pETDuet-1 by Sangon Biotech (Shanghai) Co., Ltd. after codon optimization according to the preferred codons of Escherichia coli to obtain the recombinant plasmid pETDuet-1-FMO. The nucleotide sequence of flavin-dependent monooxygenase FMO is shown in SEQ ID NO.3, and the amino acid sequence is shown in SEQ ID NO.4.
[0072] (3) Construction of indoxyl production strain
[0073] The recombinant plasmids pETDuet-1-TnaA and pETDuet-1-FMO were co-transformed into the E. coli BL21 (DE3) host bacteria, and the pCDFDuet-1 and pAcycDuet plasmids were transferred to balance the resistance. After culturing overnight at 37°C on an LB plate containing ampicillin (100 μg / mL), streptomycin (50 μg / mL) and chloramphenicol (35 μg / mL), the transformants were picked into 5 mL of LB medium (resistance was the same as above), and cultured at 37°C, 180 r / min with shaking. The resulting indoxyl preparation strain TF was obtained.
[0074] (4) Effect of TnaA overexpression on the strain's ability to catalyze tryptophan
[0075] The recombinant plasmid pETDuet-1-FMO was transformed into the E. coli BL21 (DE3) host bacteria, and the pCDFDuet-1 and pAcycDuet plasmids were transferred to balance the resistance. After culturing overnight at 37°C on an LB plate containing ampicillin (100 μg / mL), streptomycin (50 μg / mL) and chloramphenicol (35 μg / mL), the transformants were picked into 5 mL of LB medium (resistance was the same as above), and cultured at 37°C, 180 r / min shaking. The resulting strain was the control strain (strain without TnaA).
[0076] After activation and cultivation for 11 h, the recombinant TF and TnaA-free strains were transferred to 5 mL LB tubes (resistance to 100 μg / mL ampicillin, 50 μg / mL streptomycin, and 35 μg / mL chloramphenicol, respectively), and cultured at 37 °C in a shaker at 180 r / min until the biomass OD 600 When the pH was 0.8, 0.05 mM of inducer IPTG and a final concentration of 1 g / L of substrate tryptophan were added and the reaction was carried out at 30°C. Samples were taken at 24, 48, 72 and 96 h of reaction time, respectively. The samples were diluted with methanol and centrifuged at 12000 r / min for 2 min. The supernatant was filtered through a 0.22 μm organic phase filter and used for HPLC determination. The results are shown in Figure 2As shown, overexpression of TnaA significantly accelerated the rate of tryptophan consumption, indicating that it has a strong tryptophan conversion ability, thus helping to accelerate the reaction process.
[0077] Example 2 Glucosyltransferase PtUGT2 M91A / S145A Preparation and activity determination
[0078] (1) Glucosyltransferase PtUGT2 M91A / S145A Preparation
[0079] The template is glucosyltransferase PtUGT2 (GenBank accession No. BBK15461.1), which was codon-optimized according to the preferred codons of Escherichia coli and synthesized in the vector pCDFDuet-1 by Sangon Biotech (Shanghai) Co., Ltd. to obtain the recombinant plasmid pETDuet-1-PtUGT2. The nucleotide sequence of glucosyltransferase PtUGT2 is shown in SEQ ID NO.5, and the amino acid sequence is shown in SEQ ID NO.6.
[0080] A series of recombinant plasmids containing the above nucleotide sequence pCDFDuet-PtUGT2 M91A / S145A The construction steps are as follows: using the PtUGT2 sequence as a template, using the inverse PCR technique to mutate the M91 and S145 sites, replacing the methionine at position 91 of the amino acid sequence of the glucosyltransferase PtUGT2 with alanine and replacing the serine at position 145 with alanine, and obtaining the recombinant plasmid pCDFDuet-PtUGT2 carrying the mutant sequence M91A / S145A Mutant PtUGT2 M91A / S145A The nucleotide sequence is shown in SEQ ID NO.7, and the amino acid sequence is shown in SEQ ID NO.8.
[0081] (2) Glucosyltransferase PtUGT2 M91A / S145A Enzyme activity assay
[0082] The recombinant plasmids pETDuet-1-FMO, pETDuet-1-PtUGT2 and pCDFDuet-PtUGT2 M91A / S145A The transformants were transformed into E. coli BL21 (DE3) host bacteria, respectively, on LB plates with corresponding resistances (the resistances were 100 μg / mL ampicillin, 50 μg / mL streptomycin and 50 μg / mL streptomycin, respectively), cultured at 37°C overnight, and the transformants were transferred to 5 mL of LB medium (resistances were the same as above), cultured at 37°C, 180 r / min shaking, and the resulting bacterial solution was mixed with 50% glycerol in a 1:1 ratio and stored at -80°C.
[0083] PtUGT2, PtUGT2 M91A / S145A After the resuscitation of the frozen bacterial suspension of FMO, they were transferred into 5 mL LB tubes with corresponding resistance. 600 =0.6-0.8, add IPTG at final concentrations of 1 and 0.2 mM, respectively, and after induction at 18°C for 20 h, resuspend in 25 mM PB buffer, collect and break the bacteria to obtain PtUGT2 and PtUGT2 M91A / S145A The activity detection method of PtUGT2 and its mutants is as follows: a 300 μL system contains a final concentration of 50 mM pH 7.0 citric acid buffer, a final concentration of 1 mM UDPG, a final concentration of 2 mM MgCl2, a final concentration of 1 mM indole, 100 μL FMO and 20 μL PtUGT2 (or PtUGT2 M91A / S145A After reacting at 50°C for 1 h, an equal volume of methanol was added to terminate the reaction, and the amount of indole glycosides generated was detected by HPLC. Figure 3 As shown, the activity of the double mutant strain obtained was increased by 20.55% compared with the wild type.
[0084] Example 3 Cloning of Glucose Dehydrogenase GDH Gene and Introduction of NADPH Regeneration System
[0085] (1) Cloning of Glucose Dehydrogenase (GDH) Gene
[0086] Glucose dehydrogenase GDH (GenBank accession No. EC1.1.1.47) was codon-optimized according to the preferred codons of Escherichia coli and synthesized in pETDuet-1 by Sangon Biotechnology (Shanghai) Co., Ltd. to obtain the recombinant plasmid pETDuet-1-GDH. The amino acid sequence of glucose dehydrogenase GDH is shown in SEQ ID NO.9.
[0087] (2) Introduction of NADPH regeneration system
[0088] The recombinant plasmids pETDuet-1-TnaA, pETDuet-1-FMO, pCDFDuet-PtUGT2 M91A / S145A and pETDuet-1-GDH were co-transformed into the host bacteria E. coli BL21 (DE3), cultured overnight at 37°C on LB plates containing ampicillin (100 μg / mL), streptomycin (50 μg / mL) and chloramphenicol (35 μg / mL), and the transformants were picked into 5 mL of LB medium (resistance is the same as above) and cultured at 37°C with shaking at 180 r / min to obtain the TFPG strain.
[0089] The recombinant plasmids pETDuet-1-TnaA, pETDuet-1-FMO and pCDFDuet-PtUGT2 M91A / S145A The transformed strains were co-transformed into the host bacterium E. coli BL21 (DE3), cultured overnight at 37°C on LB plates containing ampicillin (100 μg / mL), streptomycin (50 μg / mL) and chloramphenicol (35 μg / mL), and the transformants were selected into 5 mL of LB medium (resistance is the same as above) and cultured at 37°C with shaking at 180 rpm to obtain the TFP strain.
[0090] (3) Detection of the effects of NADPH and its regeneration system on indole glycoside production
[0091] After the TFPG and TFP strains were revived, they were transferred into 5 mL LB tubes with corresponding resistance. 600 =0.6-0.8, add IPTG with a final concentration of 0.2mM, 1.5g / L tryptophan and 10g / L cellobiose, react at 20℃ for 24, 48, 72 and 96h, take 200μL from the system as sample and add an equal volume of methanol, mix well and centrifuge at 12000r / min for 10min, and use HPLC to detect the amount of indole glycosides generated after the supernatant passes through the membrane. The results are as follows Figure 4 As shown, the TFP strain catalytic system is the control (Ctrl), when OD 600 = 0.6-0.8 when 1 mM NADPH was added, and the TFPG strain catalytic system was recorded as GDH. The additional addition of 1 mM NADPH increased the yield by 13.1%, but shortened the reaction time, that is, the maximum yield appeared at 48h instead of 72h when NADPH was not added. It can be seen that the addition of NADPH is beneficial to the entire reaction system, while GDH needs NADP + It is used as a co-substrate with glucose to generate NADPH. + When added, the indole glycoside production was significantly lower than before optimization, which also proves the necessity of additional co-substrate addition.
[0092] Example 4 Optimization of reaction conditions of NADPH regeneration system
[0093] (1) Optimization of glucose concentration
[0094] After the TFPG strain was revived, it was transferred into a 5 mL LB tube with the corresponding resistance. 600=0.6-0.8, add IPTG with a final concentration of 0.2mM, 1.5g / L tryptophan and different concentrations of glucose (0, 5, 10, 15, 25, 50 and 100mM), react at 30°C for 48h, take 200μL sample and add an equal volume of methanol, mix well and centrifuge at 12000r / min for 10min, and use HPLC to detect the amount of indole glycosides generated after the supernatant is filtered through a 0.22μm organic phase filter. The results are as follows Figure 5 As shown in a, when the glucose concentration is lower than 25 mM, the effect on the yield of indole glycosides is small; however, as the glucose concentration increases further, the titer of indole glycosides drops sharply, and the added tryptophan is almost not converted, indicating that too high a glucose concentration will inhibit the activity of tryptophanase. Therefore, 5 mM glucose should be added to the reaction system.
[0095] (2)NADP + Concentration Optimization
[0096] After the TFPG strain was revived, it was transferred into a 5 mL LB tube with the corresponding resistance. 600 =0.6-0.8, add IPTG with a final concentration of 0.2mM, and after induction at 20℃ for 6h, add 1.5g / L tryptophan, 5mM glucose and different concentrations of NADP + (0, 0.1, 0.5, 1 and 1.5 mM), reacted at 30 ° C for 48 h, took 200 μL sample and added an equal volume of methanol, mixed and centrifuged at 12000 r / min for 10 min, and the supernatant was filtered through a 0.22 μm organic phase filter and the amount of intermediate indole and generated indole glycosides was determined by HPLC. The results are shown in Figure 5 As shown in b, the amount of indole glycosides and indole is negatively correlated. + When the addition amount was 1 mM, the indole content detected at the same time point was the lowest, which was 43.74% lower than when no addition was made, and the indole glycoside yield was the highest at this time, which was 22.39% higher than when no addition was made.
[0097] Example 5 Effects of the co-culture system and UDP-glucose circulation system on indole glycoside production
[0098] Cellobiose phospholyase Cep (GenBank accession WP_011467800.1) and glucose-1-phosphate uridyltransferase UgpA (GenBank accession WP_013389920.1) were synthesized in the vector pACYCDuet by Sangon Biotech (Shanghai) Co., Ltd. after codon optimization according to the preferred codons of Escherichia coli to obtain the recombinant plasmid pACYCDuet-Cep-UgpA. The amino acid sequence of cellobiose phospholyase Cep is shown in SEQ ID NO.10, and the amino acid sequence of glucose-1-phosphate uridyltransferase UgpA is shown in SEQ ID NO.11.
[0099] Plasmid pACYCDuet-Cep-UgpA, pCDFDuet-PtUGT2 M91A / S145A and pETDuet-1-GDH were co-transformed into the E. coli BL21 (DE3) host bacteria, and cultured overnight at 37°C on LB plates containing ampicillin (100 μg / mL), streptomycin (50 μg / mL) and chloramphenicol (35 μg / mL). Transformants were selected and transferred to 5 mL of LB medium (resistance was the same as above) and cultured at 37°C with shaking at 180 rpm. The resulting transglycosylation strain PGC was obtained.
[0100] After activation and culture for 11 h, the recombinant bacteria TF and PGC were transferred to 5 mL LB tubes (resistances were 100 μg / mL ampicillin, 50 μg / mL streptomycin, and 35 μg / mL chloramphenicol, respectively) at an inoculation ratio of 3:7, and cultured at 37 °C in a shaker at 180 r / min until the biomass OD 600 When the pH was 0.8, 0.05 mM inducer IPTG, 10 g / L cellobiose, and 1 mM NADP were added. + , 5mM glucose and a final concentration of 1.5g / L substrate tryptophan, and reacted at 30°C. Samples were taken at 24, 48, 72 and 96h of reaction time, respectively. The samples were diluted with methanol and centrifuged at 12000r / min for 10min. The supernatant was filtered through a 0.22μm organic phase filter and used for HPLC to determine the amount of indole glycosides produced. The results are shown in Figure 6As shown in the figure, compared with the titer of indole glycoside produced by tryptophan catalyzed by a single strain under the same conditions, under the same induction and reaction conditions, although the required reaction time is longer, the maximum titer of indole glycoside produced by co-culture fermentation (132.0 mg / L) is significantly higher than that of single strain fermentation (74.1 mg / L), which is about 1.78 times higher. Compared with TF-PG, the maximum titer of indole glycoside in strain TF-PGC is 211.5 mg / L, which is 1.60 times higher than that in the system without UDP-glucose, indicating that the introduction of exogenous cellobiose phosphate pathway can significantly increase the UDP-glucose content in the strain, thereby increasing the product yield.
[0101] Example 6 Optimization of fermentation medium and substrate addition conditions in co-culture system
[0102] Based on Example 5, the conditions for adding the culture medium and substrate to the co-culture system were optimized.
[0103] After activation and cultivation for 11 h, the recombinant bacteria TF and PGC were transferred to 5 mL LB tubes (resistances were 100 μg / mL ampicillin, 50 μg / mL streptomycin, and 35 μg / mL chloramphenicol, respectively) at an inoculation ratio of 3:7. The system was maintained in a microaerobic state and cultured in a shaker at 37°C at 180 r / min until the biomass OD 600 When the pH was 0.8, 0.05 mM inducer IPTG, 10 g / L cellobiose, and 1 mM NADP were added. + and 5mM glucose, and after induction at 20℃ for 6h, the substrate tryptophan was added at a final concentration of 1.5g / L, and the reaction was carried out at 30℃. Samples were taken at 24, 48, 72 and 96h of reaction time, respectively. The samples were diluted with methanol and centrifuged at 12000r / min for 10min. The supernatant was filtered through a 0.22μm organic phase filter and used for HPLC to determine the amount of indole glycosides produced. Single variables were controlled to determine the effects of different conditions, including different culture media (LB and TB), carbon source types (1% glycerol, sucrose, glucose, inulin, maltodextrin and dextrin), carbon source concentrations (0.5%, 1%, 1.5%, 2%, 2.5% and 3%), oxygen status (anaerobic, microaerobic and hyperoxic), substrate concentrations (1, 1.5, 2, 3 and 5g / L) and the timing of substrate addition (substrate was added 0, 2, 4, 6 and 8h after induction), on the amount of indole glycosides produced. The results are shown in Figure 7 As shown, when TB medium containing 1% glycerol was used, 1.5 g / L tryptophan was added as a substrate after 6 h of induction under microaerobic conditions, and the yield of indole glycosides was the highest, at 523.8 mg / L.
[0104] Example 7 Co-culture system cultivation and reaction conditions optimization
[0105] Based on Example 6, the culture and reaction conditions of the co-culture system were optimized.
[0106] After activation and cultivation for 11 h, the recombinant bacteria TF and PGC were transferred to 5 mL TB tubes containing 1% glycerol (resistances were 100 μg / mL ampicillin, 50 μg / mL streptomycin, and 35 μg / mL chloramphenicol) at an inoculation ratio of 3:7, and cultured at 37 °C in a shaker at 180 r / min until the biomass OD 600 When the pH is 0.8, add 0.05mM inducer IPTG, 10g / L cellobiose, 1mM NADP + and 5mM glucose. After induction at 25°C for 6h, the substrate tryptophan was added at a final concentration of 1.5g / L, and the reaction was carried out at 30°C. Samples were taken at 24, 48, 72 and 96h of reaction time, respectively. The samples were diluted with methanol and centrifuged at 12000r / min for 10min. The supernatant was filtered through a 0.22μm organic phase filter and used for HPLC to determine the amount of indole glycosides produced. The effects of the double strain inoculation ratio (1:9, 3:7, 5:5, 7:3 and 9:1), culture conditions and fermentation temperature (20°C, 25°C, 30°C and 37°C) on the production of indole glycosides were determined. The culture conditions included the inducer IPTG concentration (0, 0.1, 0.3, 0.5, 0.7 and 0.9mM), OD 600 (0.6, 1.0, 1.4, 1.8 and 2.2) and induction temperature (20°C, 25°C, 30°C and 37°C). Figure 8 As shown, the optimal inoculation ratio is 5:5, the cellobiose concentration is 10 g / L, the inducer concentration is 0.1 mM, the induction temperature is 20 °C, and the strain OD is 600 is 1.4 and the fermentation temperature is 25°C, under the optimal conditions, the titer of indole glycoside reaches 911.8 mg / L and the molar conversion rate is 42.1%.
[0107] The present invention provides a method for the co-transformation of two strains to biosynthesize indole glycosides, and creates a new approach and technology for the preparation of indole glycosides. The present invention utilizes tryptophanase TnaA, flavin-dependent monooxygenase FMO, and glucosyltransferase PtUGT2 M91A / S145A , UDP-glucose circulation system and NADPH regeneration system, and established a process for the biosynthesis of indole glycosides using tryptophan as a substrate. The metabolic pathways were rationally split through the co-culture system ( Figure 1 ), thus creating a new method for the efficient and low-cost biosynthesis of indole glycosides. The glucosyltransferase PtUGT2 used in the present invention M91A / S145AIt is a mutant of glucosyltransferase from Polygalatenuifolia, in which MET91 and SER145 are both mutated to ALA, and the activity is increased by 20.55%. In the established co-culture system, the metabolic pathway is split into the preparation of indoxyl and transglycosylation, and the NADPH regeneration system and UDP-glucose circulation system are introduced to greatly reduce the consumption of NADPH and the preparation cost of indole glycosides. A process for the co-culture biosynthesis of indole glycosides using tryptophan as a substrate was established. By optimizing the reaction conditions of the co-culture system (using TB medium containing 1% glycerol, strain inoculation ratio of 5:5, under microaerobic conditions, when OD 600 =1.4, add 0.1mM inducer IPTG, 10g / L cellobiose, 1mM NADP + and 5 mM glucose, after induction at 20°C for 6 h, the substrate tryptophan was added at a final concentration of 1.5 g / L, and the reaction was carried out at 25°C), the highest yield of indole glycosides reached 911.8 mg / L, and the molar conversion rate was 42.1%.
[0108] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention, which should all be included in the scope of the claims of the present invention.
Claims
1. A method for preparing indole glycosides by biocatalytic conversion of tryptophan, characterized in that: include, The indole glycosides are prepared by biocatalysis using tryptophan as a substrate by combining tryptophanase, flavin-dependent monooxygenase, glucosyltransferase, glucose dehydrogenase or combining recombinant bacteria of the above enzymes; Wherein, the tryptophanase comprises one of TnaA from Haliscomenobacter hydrossis DSM 1100, Sediminispirochaeta smaragdinae DSM 11293, and Escherichia coli B21 (DE3); The flavin-dependent monooxygenase comprises one of the FMOs derived from Hydrogenovibrio sp. JE_KL2, Pseudomonadotabacterium, and Methylophaga sp. strain SK1; The glucosyltransferase is a mutant of the glucosyltransferase PtUGT2 derived from Polygala tenuifolia, and the mutant is obtained by replacing the methionine at position 91 with alanine and the serine at position 145 with alanine in the amino acid sequence of the glucosyltransferase PtUGT2; The glucose dehydrogenase includes GDH derived from Bacilus subtilis.
2. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 1, characterized in that: The tryptophanase is selected from TnaA from Escherichia coli B21 (DE3), and the nucleotide sequence encoding the TnaA is shown in SEQ ID NO.1; The flavin-dependent monooxygenase is selected from FMO derived from Methylophaga sp. strain SK1, and the nucleotide sequence encoding the FMO is shown in SEQ ID NO.3; The nucleotide sequence encoding the glucosyltransferase PtUGT2 mutant is shown in SEQ ID NO.7; The amino acid sequence of the GDH is shown in SEQ ID NO.
9.
3. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 1 or 2, characterized in that: The biocatalytic reaction uses tryptophan as a substrate, and the recombinant bacteria are inoculated and cultured until the biomass OD 600 is 0.6-2.2, the concentration of IPTG added is 0-0.9 mM, the induction temperature is 20-37°C, the fermentation temperature is 20-37°C, the cellobiose concentration is 0-20 g / L, and the NADP + The concentration is 0-1.5 mM, the glucose concentration is 0-100 mM, and the substrate tryptophan concentration is 1.5 g / L.
4. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 3, characterized in that: The biocatalytic reaction uses tryptophan as a substrate, and the recombinant bacteria are inoculated and cultured until the biomass OD 600 is 0.6-0.8, the concentration of IPTG added is 0.2mM, the induction temperature is 20℃, the fermentation temperature is 30℃, the cellobiose concentration is 10g / L, and the NADP + The concentration was 1 mM, the glucose concentration was 10 mM, and the substrate tryptophan concentration was 1.5 g / L.
5. A method for preparing indole glycosides by biocatalytic conversion of tryptophan, characterized in that: include, The indole glycosides are prepared by biocatalysis using tryptophan as a substrate by combining tryptophanase, flavin-dependent monooxygenase, glucosyltransferase, glucose dehydrogenase, cellobiose phospholyase, glucose-1-phosphate uridyltransferase or combining recombinant bacteria of the above enzymes; Wherein, the tryptophanase comprises one of TnaA from Haliscomenobacter hydrossis DSM 1100, Sediminispirochaeta smaragdinae DSM 11293, and Escherichia coli B21 (DE3); The flavin-dependent monooxygenase includes one of the FMOs derived from Hydrogenovibrio sp. JE_KL2, Pseudomonadotabacterium, and Methylophaga sp. strain SK1; The glucosyltransferase is a mutant of the glucosyltransferase PtUGT2 derived from Polygala tenuifolia, and the mutant is obtained by replacing the methionine at position 91 with alanine and the serine at position 145 with alanine in the amino acid sequence of the glucosyltransferase PtUGT2; The glucose dehydrogenase includes GDH derived from Bacilus subtilis; The cellobiose phospholyase includes Cep derived from Saccharophagus degradans; The glucose-1-phosphate uridyltransferase includes UgpA derived from Bifidobacterium bifidum.
6. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 5, characterized in that: The tryptophanase is selected from TnaA from Escherichia coli B21 (DE3), and the nucleotide sequence encoding the TnaA is shown in SEQ ID NO.1; The flavin-dependent monooxygenase is selected from FMO derived from Methylophaga sp. strain SK1, and the nucleotide sequence encoding the FMO is shown in SEQ ID NO.3; The nucleotide sequence encoding the glucosyltransferase PtUGT2 mutant is shown in SEQ ID NO.7; The amino acid sequence of the GDH is shown in SEQ ID NO.9; The amino acid sequence of Cep is shown in SEQ ID NO.10; The amino acid sequence of UgpA is shown in SEQ ID NO.
11.
7. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 5 or 6, characterized in that: The recombinant bacteria include a first recombinant bacteria and a second recombinant bacteria, wherein the first recombinant bacteria contains a nucleotide sequence encoding a tryptophanase TnaA and a nucleotide sequence encoding a flavin-dependent monooxygenase FMO; The second recombinant bacterium contains a nucleotide sequence encoding a mutant of a glucosyltransferase PtUGT2, a nucleotide sequence encoding a glucose dehydrogenase GDH, a nucleotide sequence encoding a cellobiose phospholyase Cep, and a nucleotide sequence encoding a glucose-1-phosphate uridyltransferase UgpA; The first recombinant bacteria and the second recombinant bacteria are jointly used for biocatalytic reaction at a strain inoculation ratio of 1:9 to 9:
1.
8. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 7, characterized in that: The biocatalytic reaction uses tryptophan as a substrate, the first recombinant bacteria and the second recombinant bacteria are co-inoculated, and OD 600 is 0.6-2.2, the concentration of IPTG added is 0-0.9 mM, the induction temperature is 20-37°C, the fermentation temperature is 20-37°C, the cellobiose concentration is 0-20 g / L, and the NADP + The concentration is 0-1.5 mM, the glucose concentration is 0-100 mM, and the substrate tryptophan concentration is 1.5 g / L.
9. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 8, characterized in that: The biocatalytic reaction uses tryptophan as a substrate, the inoculation ratio of the first recombinant bacteria to the second recombinant bacteria is 1:1, and the OD 600 was 1.4, the IPTG concentration was 0.1 mM, the induction temperature was 20°C, the fermentation temperature was 30°C, the cellobiose concentration was 10 g / L, and the NADP + The concentration was 1 mM, the glucose concentration was 10 mM, and the substrate tryptophan concentration was 1.5 g / L.
10. The method for preparing indole glycosides by biocatalytic conversion of tryptophan as claimed in claim 9, characterized in that: The reaction time was 48 hours, and the in vivo conversion rate of indole glycoside was 42.1%.
Citation Information
Cited By
Tryptophan enzyme mutant and application thereof in production of indole
CN119506260A
UTP-glucose-1-phosphate uridine monophosphate transferase mutant and application thereof
CN120796233A
